Crystal's MCW Coder Hub🧠 CPT Code 64643 — Chemodenervation of One Extremity; Each Additional Extremity, 1-4 Muscle(s)
Quick Reference
📋 Clinical Description
CPT 64643 is an add-on code that reports the injection of a chemical neurolytic agent — most commonly botulinum toxin A or B — into one to four muscles of each additional extremity treated beyond the first in a single encounter. It is always reported in addition to the primary chemodenervation code (64642 when the first extremity involves 1-4 muscles, or 64644 when the first extremity involves 5 or more muscles) and cannot be submitted as a standalone code. Because it is an add-on code, modifier -51 is never applied, and no separate global period is assigned — the global period of the primary code (64642 or 64644) governs the encounter.
The clinical context for 64643 mirrors that of its parent code 64642: patients with multi-extremity spasticity from stroke, cerebral palsy, traumatic brain injury, multiple sclerosis, or spinal cord injury who require botulinum toxin injections into more than one extremity in a single session. Because there are only four extremities anatomically, the maximum number of 64643 units that can be reported in a single session is three (covering the three additional extremities beyond the one captured by the primary code). The number of muscles — not injection sites — governs whether 64643 (1-4 muscles) or 64645 (5 or more muscles) is the appropriate add-on for each additional limb.
This add-on code may be reported in the following clinical contexts:
- Bilateral upper limb spasticity — both arms treated in same session; first arm on 64642, second arm on 64643
- Bilateral lower limb spasticity — both legs treated; first leg on 64642 or 64644, second leg on 64643 or 64645
- Multi-limb spasticity — any combination of upper and lower extremities requiring injection in the same session
- Cerebral palsy (spastic diplegia or quadriplegia) — multiple extremities routinely injected together to maximize functional gains
- Spinal cord injury / quadriplegia — all four extremities may require injection in a single session; 64642 + 64643 × 3
🔬 Add-On Code Logic & Reporting Rules
| Extremity Injected | # Muscles | Code to Report |
|---|---|---|
| 1st extremity (any limb) | 1-4 | 64642 — primary code |
| 1st extremity (any limb) | 5 or more | 64644 — primary code |
| Each additional extremity | 1-4 | 64643 — add-on (this code) |
| Each additional extremity | 5 or more | 64645 — add-on |
Clinical Pearl — Add-On Code Rules
64643 follows the add-on code contract: it is never billed alone, never gets modifier -51, and its payment is not subject to the multiple procedure reduction rule. Its wRVU of 1.22 is paid in full in addition to the primary code’s payment — not reduced by 50% like bilateral procedures under indicator 1. For a four-extremity session, the total wRVU stack is: 64642 (1.61) + 64643 × 3 (1.22 × 3 = 3.66) = 5.27 total wRVU before any facility vs. non-facility PE adjustment.
✅ Procedure Includes
- Needle placement into 1-4 muscles of the additional target extremity, percutaneous
- Injection of botulinum toxin or other chemical neurolytic agent into the targeted muscle(s) of the additional limb
- Needle repositioning within the same muscle for multi-site injection within one muscle (not counted as additional muscles)
- Post-injection monitoring for that extremity
- Documentation of: specific muscle(s) injected in this additional limb, laterality, injection technique, agent used, dosage, and clinical rationale
✅ Separately Reportable (Not Included)
- 95874 — Needle EMG guidance in conjunction with chemodenervation; this is a per-extremity add-on — a separate unit of 95874 may be reported for each additional extremity where EMG guidance is used; do not report 95873 and 95874 together
- 76942 — Ultrasonic guidance for needle placement, imaging supervision and interpretation; typically reported once per session; verify payer policy on units when guidance is used for multiple extremities
- J0585 — OnabotulinumtoxinA (Botox), per unit — drug is always billed separately; total units across all extremities billed on a single line or separate lines depending on payer requirements
- J0586 — AbobotulinumtoxinA (Dysport), per 5 units
- J0587 — RimabotulinumtoxinB (Myobloc), per 100 units
- J0588 — IncobotulinumtoxinA (Xeomin), per unit
❌ Excludes / Do Not Report Together
| Code | Description | Relationship to 64643 |
|---|---|---|
| Standalone billing | N/A | 64643 cannot be reported without 64642 or 64644 on the same claim — it will be denied as an orphaned add-on code |
| 64645 | Chemodenervation, each additional extremity; 5 or more muscle(s) | Mutually exclusive with 64643 for the same additional extremity — use 64645 when 5 or more muscles are injected in that additional limb; do NOT report both for the same limb |
| 64642 | Chemodenervation, 1 extremity; 1-4 muscle(s) | 64643 is added to 64642, not reported alongside a second unit of 64642; never bill 64642 twice for two extremities — the second extremity always uses the add-on |
| 64615 | Chemodenervation; facial, trigeminal, cervical spinal, and accessory nerve muscles | CPT parenthetical guidelines prohibit reporting 64615 in conjunction with the extremity chemodenervation family |
Critical Add-On Code Alert
64643 is a ”+” designated add-on code in CPT. It is NEVER reported without its parent code on the same claim. A claim that includes only 64643 without 64642 or 64644 will be systematically denied. This is the most common processing error when the primary code is denied (eg, for authorization issues) and the add-on remains — if 64642 is denied, 64643 must also be adjusted off the claim. Track add-on/primary code pairs as a linked billing unit.
🌳 Code Tree — Destruction by Neurolytic Agent (Extremity Chemodenervation)
CPT 64600-64681 Surgery: Destruction by Neurolytic Agent
│
├── 64612-64617 Chemodenervation — Head, Neck, Larynx
│ ├── 64612 Chemodenervation; facial nerve muscle(s), unilateral
│ ├── 64615 Chemodenervation; facial, trigeminal, cervical spinal, accessory nerves
│ ├── 64616 Chemodenervation; neck muscle(s), excluding laryngeal
│ └── 64617 Chemodenervation; larynx, for spasmodic dysphonia
│
├── 64642 Chemodenervation, 1 extremity; 1-4 muscle(s) ← PRIMARY PARENT CODE
├── ▶▶ +64643 ◀◀ Chemodenervation, EACH ADDITIONAL extremity; 1-4 muscle(s) ← YOU ARE HERE
│ └── [Add-on to 64642 or 64644 | Max 3 units per session | No modifier -51]
│
├── 64644 Chemodenervation, 1 extremity; 5 or more muscle(s) ← ALTERNATE PRIMARY
├── +64645 Chemodenervation, each additional extremity; 5 or more muscle(s) [Add-on to 64644 or 64642]
│
├── 64646 Chemodenervation of trunk muscle(s); 1-5 muscle(s)
└── +64647 Chemodenervation of trunk muscle(s); each additional trunk muscle [Add-on]
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 1.22 |
| Global Period | ZZZ — Add-on Code (global of primary code applies) |
| Add-On Code | ✅ Yes — must be reported with 64642 or 64644 |
| Modifier -51 Exempt | ✅ Yes — add-on codes are exempt by definition |
| Multiple Procedure Reduction | ❌ Does not apply — paid in full alongside primary code |
| Max Units Per Session | 3 (one per additional extremity; 4 extremities total - 1 primary = 3 add-ons) |
| Assistant Surgeon | ❌ Not payable |
| PC/TC Split | ❌ No — procedure code only (Indicator 0) |
Full Session RVU Stack Example — Quad Limb Spasticity
Code Description wRVU 64642 First extremity, 1-4 muscles 1.61 64643 × 1 Second extremity, 1-4 muscles 1.22 64643 × 2 Third extremity, 1-4 muscles 1.22 64643 × 3 Fourth extremity, 1-4 muscles 1.22 95874 × up to 4 EMG guidance, per extremity varies Total (procedure codes only) 5.27 wRVU The drug J-codes (J0585-J0588) generate separate reimbursement on top of the procedure wRVU stack and often represent the majority of total payment for the encounter.
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -RT | Right Side | Identifies the specific additional extremity as right-sided; not required for payment but strongly recommended for documentation clarity and audit trail |
| -LT | Left Side | Identifies left-sided additional extremity treatment |
| -59 | Distinct Procedural Service | Rarely needed; only if a payer incorrectly attempts to bundle this add-on with the primary or another code; documents distinct anatomic site |
| ❌ NEVER use -51 on 64643 — add-on codes are exempt from modifier -51; applying it is incorrect and may reduce payment | ||
| ❌ Not applicable — bilateral extremity involvement is reported by stacking 64643 units, not by using -50 on the primary code |
🩺 Common ICD-10-CM Pairings
Note
The diagnosis codes reported with 64643 mirror those reported with the primary code 64642 on the same claim. The same ICD-10-CM diagnoses that justify the primary chemodenervation also justify the additional extremity add-on — no separate or different diagnosis code is required for each add-on line. List all applicable diagnosis codes on the claim header and link them appropriately to both the primary and add-on procedure lines.
Multi-Extremity Spasticity — Highest-Yield Pairings
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Clinical Notes |
|---|---|---|---|---|
| G80.0 | Spastic quadriplegic cerebral palsy | ✅ Yes | HCC Motor/Cognitive | Most common driver of a full four-extremity session; supports 64642 + 64643 × 3 |
| G80.1 | Spastic diplegic cerebral palsy | ✅ Yes | HCC Motor/Cognitive | Bilateral lower limb involvement; supports 64642 + 64643 × 1 for bilateral lower extremity session |
| G82.50 | Quadriplegia, unspecified | ✅ Yes | HCC Motor/Cognitive | SCI etiology; all four limbs potentially involved |
| G82.20 | Paraplegia, unspecified | ✅ Yes | HCC Motor/Cognitive | Bilateral lower limb; supports 64642 + one unit of 64643 |
| G35.- | Multiple sclerosis | ✅ Yes | HCC Demyelinating | Episodic or progressive multi-limb spasticity; document progressive vs. relapsing-remitting course |
| G81.10 | Spastic hemiplegia, unspecified side | ✅ Yes | HCC Motor/Cognitive | One upper + one lower extremity ipsilateral; supports 64642 + 64643 × 1 |
| I69.351 | Hemiplegia following cerebral infarction, right dominant side | ✅ Yes | Stroke Sequelae HCC | Most specific post-stroke code when laterality and dominance are documented |
| I69.352 | Hemiplegia following cerebral infarction, left dominant side | ✅ Yes | Stroke Sequelae HCC | Left-sided post-stroke hemiplegia |
| G24.1 | Genetic torsion dystonia | ❌ No | N/A | Multi-limb dystonia; less common indication for multi-extremity chemodenervation |
HCC Mapping Note
Many of the diagnosis codes pairing with 64642/64643 carry significant HCC weight under CMS-HCC Model v28 — particularly the hemiplegia (G81.xx), paraplegia/quadriplegia (G82.xx), and stroke sequelae (I69.3xx) categories. For Medicare Advantage patients, accurate and complete diagnosis capture on the chemodenervation encounter directly impacts RAF scoring. Ensure each underlying neurological condition is coded to its highest level of specificity and is supported by current-encounter documentation, not just historical records.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 64643 is not used in the inpatient facility setting — ICD-10-PCS governs inpatient procedure coding. As an add-on code, 64643 carries a ZZZ global period and has no independent MS-DRG mapping. In the inpatient setting, the same PCS code used for the primary chemodenervation (3E0M3GC) would typically be assigned once or multiple times depending on facility policy for multi-extremity sessions. The DRG assignment is driven entirely by the principal diagnosis and CC/MCC capture — not the chemodenervation procedure itself.
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
| PCS Code | Full Description | Notes |
|---|---|---|
3E0M3GC | Introduction of Other Therapeutic Substance into Muscle, Percutaneous Approach | Same PCS code used for the primary and add-on extremities; assign once or per-extremity per facility policy |
PCS Character Analysis — 3E0M3GC
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Root Operation | 0 | Introduction (putting in or on a therapeutic substance) |
| 4 | Body Part | M | Muscle |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | G | Other Therapeutic Substance |
| 7 | Qualifier | C | Other Substance |
Multi-Extremity PCS Guidance
Unlike CPT, which has a distinct add-on code structure, ICD-10-PCS does not have a tiered extremity-counting mechanism. The body part character “M” (Muscle) does not differentiate between first and additional extremities. Most inpatient coding teams assign one instance of 3E0M3GC for the encounter regardless of how many extremities were injected. Some facilities may assign multiple lines to reflect the bilateral or multi-limb nature of the session — confirm with your facility’s PCS coding policy before doing so.
📝 Coding Examples
Example 1 — Office: Bilateral Lower Extremity Spasticity, 1-4 Muscles Each, Spastic Diplegia
Clinical Scenario: A 10-year-old with spastic diplegic cerebral palsy presents for bilateral lower extremity botulinum toxin injections. The physician injects onabotulinumtoxinA into the right gastrocnemius (50 units) and right hamstrings (50 units) — 2 muscles right lower extremity — and the left gastrocnemius (50 units) and left hamstrings (50 units) — 2 muscles left lower extremity. EMG guidance used bilaterally. Total dose: 200 units.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64642-RT | Chemodenervation, right lower extremity; 2 muscles — primary code |
| CPT 2 | 64643-LT | Chemodenervation, left lower extremity; 2 muscles — add-on; no modifier -51 |
| CPT 3 | 95874 | EMG guidance; one unit — verify per-extremity vs. per-session billing with MAC |
| Drug | J0585 × 200 | OnabotulinumtoxinA, 200 units total administered |
| PDx | G80.1 | Spastic diplegic cerebral palsy |
Note
Example 2 — Office: Three-Extremity Session, Mixed Muscle Counts, Post-TBI Spasticity
Clinical Scenario: A 38-year-old male with traumatic brain injury and spastic right hemiplegia presents for chemodenervation. The physician injects: right upper extremity — 3 muscles (biceps, FCR, FDS); right lower extremity — 2 muscles (gastrocnemius, tibialis posterior); left lower extremity — 1 muscle (iliopsoas). Ultrasound guidance is used. No separately identifiable E/M documented.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64642-RT | First extremity (right upper), 3 muscles — primary code |
| CPT 2 | 64643-RT | Second extremity (right lower), 2 muscles — first add-on unit |
| CPT 3 | 64643-LT | Third extremity (left lower), 1 muscle — second add-on unit |
| CPT 4 | 76942 | Ultrasound guidance; report once per session (confirm payer policy) |
| PDx | G81.11 | Spastic hemiplegia affecting right dominant side — primary neurological condition driving spasticity |
Warning
Right upper and right lower extremities are two distinct extremities and each requires a separate code line. A common error is to bundle ipsilateral upper and lower limb injections into a single 64642 unit — this is incorrect. Each anatomically distinct extremity (upper arm, lower leg) is a separate reporting unit regardless of laterality.
Example 3 — Office: Four-Extremity Session, Quad Limb Spasticity, MS, with E/M
Clinical Scenario: A 47-year-old female with secondary progressive multiple sclerosis presents for quarterly quad limb botulinum toxin injections. All four extremities are injected with 2-3 muscles each. The physician also documents a separately identifiable E/M — new-onset lower extremity edema is evaluated, DVT is ruled out clinically, and a compression stocking recommendation is made. This is documented as distinct from the pre-injection spasticity assessment.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 99213-25 | E/M, established patient, low-moderate complexity; -25 on the E/M — documentation must clearly reflect separate MDM for the edema evaluation |
| CPT 2 | 64642 | First extremity (any of the four), 2-3 muscles — primary code |
| CPT 3 | 64643 | Second extremity, 2-3 muscles — first add-on |
| CPT 4 | 64643 | Third extremity, 2-3 muscles — second add-on |
| CPT 5 | 64643 | Fourth extremity, 2-3 muscles — third add-on (maximum) |
| PDx | G35.- | Multiple sclerosis |
Note
⚠️ Common Coding Pitfalls
-
Billing 64643 without its primary code: 64643 is an add-on code and will be denied on any claim that does not also include 64642 or 64644. If the primary code is retracted, adjusted, or denied, the add-on must be adjusted off the claim simultaneously.
-
Using modifier -51 on 64643: Add-on codes are exempt from modifier -51 by definition. Applying -51 to 64643 is a coding error that may result in a multiple procedure payment reduction that is not appropriate for this code.
-
Billing more than 3 units of 64643 per session: The anatomical maximum is 3 additional extremities (4 total extremities minus the 1 primary). Billing 4 or more units will be denied by MUE. If all four extremities were treated, the correct claim structure is 64642 × 1 + 64643 × 3.
-
Mixing 64643 and 64645 incorrectly: If the second extremity has 1-4 muscles injected, use 64643. If it has 5 or more muscles, use 64645. These are not interchangeable. Verify the muscle count for each additional extremity independently.
-
Omitting the drug J-code: Every botulinum toxin injection encounter should include the appropriate J-code (J0585, J0586, J0587, or J0588) billed for the total units administered. The drug J-code is a separate line item and often accounts for the majority of total reimbursement for the encounter. Not billing it is a significant revenue cycle error.
-
Conflating add-on with bilateral modifier: 64643 is NOT a bilateral modifier equivalent. It is a per-extremity add-on code. Do NOT append modifier -50 to 64642 expecting it to cover both extremities — the second extremity requires its own 64643 line.
📎 Sources
AMA CPT 2025 Professional Edition · CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) · CMS RVU25A Relative Value Files · CMS Billing and Coding Article A57185 — Botulinum Toxin Injections · CMS Billing and Coding Article A52848 — Botulinum Toxins · NCCI Policy Manual Chapter 11 (Nervous System), CMS 2024-2025 · UHC Global Days Policy — ZZZ Add-on Code Definition · ICD-10-CM Official Guidelines for Coding and Reporting FY2025 · ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 · AAPC Neurology/PM&R Coding Reference 2025 · Frontiers in Neurology — Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Resource Use (PMC10427537) · Practical Neurology — Botulinum Toxin Billing & Coding Update (2026) · Ambu USA — Myoguide CPT Coding Reference